New therapies for the treatment of Parkinson's disease: Adenosine A 2A receptor antagonists

Life Sciences

Volumn 77, Issue 26, 2005, Pages 3259-3267

  Pinna, Annalisa ^a,b   Wardas, Jadwiga ^c   Simola, Nicola ^b   Morelli, Micaela ^a,b  

^a CNR   (Italy)

^b UNIVERSITY OF CAGLIARI   (Italy)

^c INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

A2A antagonist; Adenosine; Dyskinesia; Motor behavior; Parkinson

Indexed keywords

2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 4 AMINOBUTYRIC ACID; 5 AMINO 2 (2 FURYL) 7 (2 PHENYLETHYL)PYRAZOLO[4,3 E][1,2,4]TRIAZOLO[1,5 C]PYRIMIDINE; ADENOSINE A2 RECEPTOR AGONIST; ADENOSINE A2 RECEPTOR ANTAGONIST; ISTRADEFYLLINE; LEVODOPA;

4 AMINOBUTYRIC ACID RELEASE; CLINICAL TRIAL; DRUG EFFECT; DYSKINESIA; HUMAN; LOCOMOTION; LOW DRUG DOSE; MOTOR DYSFUNCTION; NONHUMAN; PARKINSON DISEASE; REVIEW; RODENT; TREMOR;

PARKINSONIA; PRIMATES; RODENTIA;

EID: 26444445618     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2005.04.029     Document Type: Short Survey

References (66)

1. 2A receptor antagonist Journal of Neuroscience 20 15 2000 5848 5852
2. A. Ascherio, S.M. Zhang, M.A. Hernan, I. Kawachi, G.A. Colditz, F.E. Speizer, and W.C. Willett Prospective study of caffeine consumption and risk of Parkinson's disease in men and women Annals of Neurology 50 1 2001 56 63
3. R.A. Barraco, K.A. Martens, M. Parizon, and H.J. Normile Adenosine A2a receptors in the nucleus accumbens mediate locomotor depression Brain Research Bulletin 31 3-4 1993 397 404
4. F. Bibbiani, J.D. Oh, J.P. Petzer, N. Castagnoli Jr., J.F. Chen, M.A. Schwarzschild, and T.N. Chase A2A antagonist prevents dopamine agonist-induced motor complications in animal models of Parkinson's disease Experimental Neurology 184 1 2003 285 294
5. S.J. Brown, S. James, M. Reddington, and P.J. Richardson Both A1 and A2a purine receptors regulate striatal acetylcholine release Journal of Neurochemistry 55 1 1990 31 38
6. A.R. Carta, A. Pinna, O. Cauli, and M. Morelli Differential regulation of GAD67, enkephalin and dynorphin mRNAs by chronic-intermittent l-dopa and A2A receptor blockade plus l-dopa in dopamine-denervated rats Synapse 44 3 2002 166 174
7. T.N. Chase, F. Bibbiani, W. Bara-Jimenez, T. Dimitrova, and J.D. Oh-Lee Translating A2A antagonist KW6002 from animal models to parkinsonian patients Neurology 61 11S6 2003 S107 S111
8. 2A and D2 receptor knockout mice Proceedings of the National Academy of Sciences of the United States of America 98 4 2001 1970 1975
9. J.F. Chen, K. Xu, J.P. Petzer, R. Staal, Y.H. Xu, M. Beilstein, P.K. Sonsalla, K. Castagnoli, N. Castagnoli Jr., and M.A. Schwarzschild Neuroprotection by caffeine and A(2A) adenosine receptor inactivation in a model of Parkinson's disease Journal of Neuroscience 21 10 2001 1 6
10. K. Chergui, A. Bouron, E. Normand, and C. Mulle Functional GluR6 kainate receptors in the striatum: indirect downregulation of synaptic transmission Journal of Neuroscience 20 6 2000 2175 2182
11. R.A. Cunha Adenosine as a neuromodulator and as a homeostatic regulator in the nervous system: different roles, different sources and different receptors Neurochemistry International 38 2 2001 107 125
12. S. Dasgupta, S. Ferré, B. Kull, P.B. Hedlund, U.B. Finnman, S. Ahlberg, E. Arenas, B.B. Fredholm, and K. Fuxe Adenosine A2A receptors modulate the binding characteristics of dopamine D2 receptors in stably cotransfected fibroblast cells European Journal of Pharmacology 316 2-3 1996 325 331
13. M.J. Durcan, and P.F. Morgan Evidence for adenosine A2 receptor involvement in the hypomobility effects of adenosine analogues in mice European Journal of Pharmacology 168 3 1989 285 290
14. S. Fenu, A. Pinna, E. Ongini, and M. Morelli Adenosine A2A receptor antagonism potentiates l-dopa-induced turning behaviour and c-fos expression in 6-hydroxydopamine-lesioned rats European Journal of Pharmacology 321 2 1997 143 147
15. 2 receptors in the neostriatum Brain Research 594 1 1992 124 130
16. S. Ferré, G. von Euler, B. Johansson, B.B. Fredholm, and K. Fuxe Stimulation of high-affinity adenosine A2 receptors decreases the affinity of dopamine D2 receptors in rat striatal membranes Proceedings of the National Academy of Sciences of the United States of America 88 16 1991 7238 7241
17. S. Ferré, K. Fuxe, G. von Euler, B. Johansson, and B.B. Fredholm Adenosine-dopamine interactions in the brain Neuroscience 51 3 1992 501 512
18. S. Ferré, W.T. O'Connor, K. Fuxe, and U. Ungerstedt The striopallidal neuron: a main locus for adenosine-dopamine interactions in the brain Journal of Neuroscience 13 12 1993 5402 5406
19. S. Ferré, B.B. Fredholm, M. Morelli, P. Popoli, and K. Fuxe Adenosine-dopamine receptor-receptor interactions as an integrative mechanism in the basal ganglia Trends in Neurosciences 20 10 1997 482 487
20. S. Ferré, M. Karcz-Kubicha, B.T. Hope, P. Popoli, J. Burgueno, M.A. Gutierrez, V. Casado, K. Fuxe, S.R. Goldberg, C. Lluis, R. Franco, and F. Ciruela Synergistic interaction between adenosine A2A and glutamate mGlu5 receptors: implications for striatal neuronal function Proceedings of the National Academy of Sciences of the United States of America 99 18 2002 11940 11945
21. J.S. Fink, D.R. Weaver, S.A. Rivkees, R.A. Peterfreund, A. Pollack, E.M. Adler, and S.M. Reppert Molecular cloning of the rat A2 adenosine receptor: selective co-expression with D2 dopamine receptors in rat striatum Molecular Brain Research 14 3 1992 186 195
22. S. Fredduzzi, R. Moratalla, A. Monopoli, B. Cuellar, K. Xu, E. Ongini, F. Impagnatiello, M.A. Schwarzschild, and J.F. Chen Persistent behavioral sensitization to chronic l-DOPA requires A2A adenosine receptors Journal of Neuroscience 22 3 2002 1054 1062
23. B.B. Fredholm, A.P. IJzerman, K.A. Jacobson, K.N. Klotz, and J. Linden International Union of Pharmacology: XXV. Nomenclature and classification of adenosine receptors Pharmacological Reviews 53 4 2001 527 552
24. C.R. Gerfen, T.M. Engber, L.C. Mahan, Z. Susel, T.N. Chase, F.J. Monsma Jr., and D.R. Sibley D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons Science 250 4986 1990 1429 1432
25. S. Gines, J. Hillion, M. Torvinen, S. Le Crom, V. Casado, E.I. Canela, S. Rondin, J.Y. Lew, S. Watson, M. Zoli, L.F. Agnati, P. Verniera, C. Lluis, S. Ferré, K. Fuxe, and R. Franco Dopamine D1 and adenosine A1 receptors form functionally interacting heteromeric complexes Proceedings of the National Academy of Sciences of the United States of America 97 15 2000 8606 8611
26. G. Griebel, M. Saffroy-Spittler, R. Misslin, D. Remmy, E. Vogel, and J.J. Bourguignon Comparison of the behavioural effects of an adenosine A1/A2-receptor antagonist, CGS 15943A, and an A1-selective antagonist, DPCPX Psychopharmacology (Berl) 103 4 1991 541 544
27. R. Grondin, P.J. Bedard, A. Hadj Tahar, L. Gregoire, A. Mori, and H. Kase Antiparkinsonian effect of a new selective adenosine A2A receptor antagonist in MPTP-treated monkeys Neurology 52 8 1999 1673 1677
28. W. Hauber, and M. Munkle Motor depressant effects mediated by dopamine D2 and adenosine A2A receptors in the nucleus accumbens and the caudate-putamen European Journal of Pharmacology 323 2-3 1997 127 131
29. R.A. Hauser, J.P. Hubble, D.D. Truong Istradefylline US-001 Study Group Randomized trial of the adenosine A(2A) receptor antagonist istradefylline in advanced PD Neurology 61 3 2003 297 303
30. B. Henry, A.R. Crossman, and J.M. Brotchie Characterization of enhanced behavioral responses to l-DOPA following repeated administration in the 6-hydroxydopamine-lesioned rat model of Parkinson's disease Experimental Neurology 151 2 1998 334 342
31. 2A receptors suggests multiple cellular sites for modulation of GABAergic neurons in rat striatum Journal of Comparative Neurology 431 3 2001 331 346
32. 3H]CGS 21680 European Journal of Pharmacology 168 2 1989 243 246
33. H. Jiang, V. Jackson-Lewis, U. Muthane, A. Dollison, M. Ferreira, A. Espinosa, B. Parsons, and S. Przedborski Adenosine receptor antagonists potentiate dopamine receptor agonist-induced rotational behavior in 6-hydroxydopamine-lesioned rats Brain Research 613 2 1993 347 351
34. T. Kanda, M.J. Jackson, L.A. Smith, R.K. Pearce, J. Nakamura, H. Kase, Y. Kuwana, and P. Jenner Adenosine A2A antagonist: a novel antiparkinsonian agent that does not provoke dyskinesia in parkinsonian monkeys Annals of Neurology 43 4 1998 507 513
35. T. Kanda, M.J. Jackson, L.A. Smith, R.K. Pearce, J. Nakamura, H. Kase, Y. Kuwana, and P. Jenner Combined use of the adenosine A(2A) antagonist KW-6002 with l-DOPA or with selective D1 or D2 dopamine agonists increases antiparkinsonian activity but not dyskinesia in MPTP-treated monkeys Experimental Neurology 162 2 2000 321 327
36. D.S. Kim, and R.D. Palmiter Adenosine receptor blockade reverses hypophagia and enhances locomotor activity of dopamine-deficient mice Proceedings of the National Academy of Sciences of the United States of America 100 3 2003 1346 1351
37. I.P. Kirk, and P.J. Richardson Adenosine A2a receptor-mediated modulation of striatal [3H]GABA and [3H]acetylcholine release Journal of Neurochemistry 62 3 1994 960 966
38. B. Kull, P. Svenningsson, and B.B. Fredholm Adenosine A(2A) receptors are colocalized with and activate g(olf) in rat striatum Molecular Pharmacology 58 4 2000 771 777
39. M. Kurokawa, I.P. Kirk, K.A. Kirkpatrick, H. Kase, and P.J. Richardson Inhibition by KF17837 of adenosine A2A receptor-mediated modulation of striatal GABA and ACh release British Journal of Pharmacology 113 1 1994 43 48
40. S. Latini, and F. Pedata Adenosine in the central nervous system: release mechanisms and extracellular concentrations Journal of Neurochemistry 79 3 2001 463 484
41. C. Le Moine, P. Svenningsson, B.B. Fredholm, and B. Bloch Dopamine-adenosine interactions in the striatum and the globus pallidus: inhibition of striatopallidal neurons through either D2 or A2A receptors enhances D1 receptor-mediated effects on c-fos expression Journal of Neuroscience 17 20 1997 8038 8048
42. P.A. LeWitt Off time reduction from adjunctive use of istradefylline (KW-6002) in levodopa-treated patients with advanced Parkinson's disease Wiley-Liss Eighth International Congress of Parkinson's Disease and Movement Disorders Rome, Italy; June 14-17, 2004 Movement Disorders vol. 19 (suppl. 9) 2004 S222 abstract no P624
43. M. Lundblad, E. Vaudano, and M.A. Cenci Cellular and behavioural effects of the adenosine A2a receptor antagonist KW-6002 in a rat model of l-DOPA-induced dyskinesia Journal of Neurochemistry 84 6 2003 1398 1410
44. 2 receptor interaction in globus pallidus Synapse 22 2 1996 132 138
45. M. Morelli, S. Fenu, A. Pinna, and G. Di Chiara Adenosine A2 receptors interact negatively with dopamine D1 and D2 receptors in unilaterally 6-hydroxydopamine-lesioned rats European Journal of Pharmacology 251 1 1994 21 25
46. M. Morelli, A. Pinna, J. Wardas, and G. Di Chiara Adenosine A2 receptors stimulate c-fos expression in striatal neurons of 6-hydroxydopamine-lesioned rats Neuroscience 67 1 1995 49 55
47. A. Mori, T. Shindou, M. Ichimura, H. Nonaka, and H. Kase The role of adenosine A2a receptors in regulating GABAergic synaptic transmission in striatal medium spiny neurons Journal of Neuroscience 16 2 1996 605 611
48. A. Pinna, G. Di Chiara, J. Wardas, and M. Morelli Blockade of A2a adenosine receptors positively modulates turning behaviour and c-Fos expression induced by D1 agonists in dopamine-denervated rats European Journal of Neuroscience 8 6 1996 1176 1181
49. A. Pinna, S. Fenu, and M. Morelli Motor stimulant effect of the adenosine A2A receptor antagonist SCH 58261 do not develop tolerance after repeated treatment in 6-hydroxydopamine-lesioned rats Synapse 39 3 2001 233 238
50. A.E. Pollack, and J.S. Fink Synergistic interaction between an adenosine antagonist and a D1 dopamine agonist on rotational behavior and striatal c-Fos induction in 6-hydroxydopamine-lesioned rats Brain Research 743 1-2 1996 124 130
51. R. Rimondini, S. Ferre, S.O. Ogren, and K. Fuxe Adenosine A2A agonists: a potential new type of atypical antipsychotic Neuropsychopharmacology 17 2 1997 82 91
52. S.A. Rivkees, S.L. Price, and F.C. Zhou Immunohistochemical detection of A1 adenosine receptors in rat brain with emphasis on localization in the hippocampal formation, cerebral cortex, cerebellum, and basal ganglia Brain Research 677 2 1995 193 203
53. 2A receptors in the rat central nervous system Journal of Comparative Neurology 401 2 1998 163 186
54. J.D. Salamone, A.J. Mayorga, J.T. Trevitt, M.S. Cousins, A. Conlan, and A. Nawab Tremulous jaw movements in rats: a model of parkinsonian tremor Progress in Neurobiology 56 6 1998 591 611
55. H. Salim, S. Ferre, A. Dalal, R.A. Peterfreund, K. Fuxe, J.D. Vincent, and P.M. Lledo Activation of adenosine A1 and A2A receptors modulates dopamine D2 receptor-induced responses in stably transfected human neuroblastoma cells Journal of Neurochemistry 74 1 2000 432 439
56. S.N. Schiffmann, O. Jacobs, and J.-J. Vanderhaeghen Striatal restricted adenosine A2 receptor (RDC8) is expressed by enkephalin but not by substance P neurons: an in situ hybridization histochemistry study Journal of Neurochemistry 57 3 1991 1062 1067
57. A.M. Sebastiao, and J.A. Ribeiro Adenosine A2 receptor-mediated excitatory actions on the nervous system Progress in Neurobiology 48 3 1996 167 189
58. N. Simola, S. Fenu, P.G. Baraldi, M.A. Tabrizi, and M. Morelli Blockade of adenosine A2A receptors antagonizes parkinsonian tremor in the rat tacrine model by an action on specific striatal regions Experimental Neurology 189 1 2004 182 188
59. J.J. Soghomonian, C. Gonzales, and M.F. Chesselet Messenger RNAs encoding glutamate-decarboxylases are differentially affected by nigrostriatal lesions in subpopulations of striatal neurons Brain Research 576 1 1992 68 79
60. 2A receptor messenger RNA in the rat central nervous system with special reference to dopamine innervated areas Neuroscience 80 4 1997 1171 1185
61. P. Svenningsson, G.G. Nomikos, E. Ongini, and B.B. Fredholm Antagonism of adenosine A2A receptors underlies the behavioural activating effect of caffeine and is associated with reduced expression of messenger RNA for NGFI-A and NGFI-B in caudate-putamen and nucleus accumbens Neuroscience 79 3 1997 753 764
62. P. Svenningsson, M. Lindskog, C. Ledent, M. Parmentier, P. Greengard, B.B. Fredholm, and G. Fisone Regulation of the phosphorylation of the dopamine- and cAMP-regulated phosphoprotein of 32 kDa in vivo by dopamine D1, dopamine D2, and adenosine A2A receptors Proceedings of the National Academy of Sciences of the United States of America 97 4 2000 1856 1860
63. S.V. Vellucci, D.J. Sirinathsinghji, and P.J. Richardson Adenosine A2 receptor regulation of apomorphine-induced turning in rats with unilateral striatal dopamine denervation Psychopharmacology (Berl) 111 3 1993 383 388
64. J. Wardas, J. Konieczny, and E. Lorenc-Koci SCH 58261, an A(2A) adenosine receptor antagonist, counteracts parkinsonian-like muscle rigidity in rats Synapse 41 2 2001 160 171
65. N.R. Zahniser, J.K. Simosky, R.D. Mayfield, C.A. Negri, T. Hanania, G.A. Larson, M.A. Kelly, D.K. Grandy, M. Rubinstein, M.J. Low, and B.B. Fredholm Functional uncoupling of adenosine A(2A) receptors and reduced response to caffeine in mice lacking dopamine D2 receptors Journal of Neuroscience 20 16 2000 5949 5957
66. B.-Y. Zeng, G.M. Pearce, G.M. MacKenzie, and P. Jenner Alterations in preproenkephalin and adenosine-2a receptor mRNA, but not preprotachykinin mRNA correlate with occurrence of dyskinesia in normal monkeys chronically treated with l-DOPA European Journal of Neuroscience 12 3 2000 1096 1104